Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98
Completed · Phase 3
Conditions studied: Open-Angle Glaucoma, Ocular Hypertension
In brief
The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.
Key facts
- Study ID
- NCT00047593
- Run by
- Alcon Research
- Starts
- 2000-01-01
- Expected to finish
- 2004-07-01
- Last updated by the study team
- 2008-08-05
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Los Angeles, California, United States
- Study site — San Francisco, California, United States
- Study site — Honolulu, Hawaii, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.